| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/05/2006 | US20060003413 Novel human protein kinase, phosphatase, and protease family members and uses thereof |
| 01/05/2006 | US20060003411 Mutated D-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060003409 Novel molecules of the card-related protein family and uses thereof |
| 01/05/2006 | US20060003408 Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions |
| 01/05/2006 | US20060003403 Carotenoid ketolase genes with improved ketocarotenoid yield |
| 01/05/2006 | US20060003358 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/05/2006 | US20060003355 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/05/2006 | US20060003341 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 01/05/2006 | US20060003330 Streptococcus pneumoniae pbp2x mini-protein and uses thereof |
| 01/05/2006 | US20060002993 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response |
| 01/05/2006 | US20060002951 Inhibition of the tRNALys3-primed initiation of reverse transcription in HIV-1 by APOBEC3G |
| 01/05/2006 | US20060002918 Thrombin compositions |
| 01/05/2006 | US20060002916 Cleavage of VEGF and VEGF receptor by wildtype and mutant MT-SP1 |
| 01/05/2006 | US20060002893 Targeted adenovirus vectors for delivery of heterologous genes |
| 01/05/2006 | DE102004029112A1 Alkoholdehydrogenase zur stereoselektiven Gewinnung von Hydroxyverbindungen Alcohol for the stereoselective production of hydroxy |
| 01/05/2006 | CA2589563A1 Method of screening compound directly activating glycogen synthase |
| 01/05/2006 | CA2571341A1 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 01/05/2006 | CA2568807A1 Method for increasing pathogen-resistance in transgenic plants by expression of peroxidase |
| 01/05/2006 | CA2549830A1 Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells |
| 01/04/2006 | EP1612274A1 Process for purifying difructose-dianhydride iii |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612271A2 Multiply-substituted protease variants with altered net charge for use in detergents |
| 01/04/2006 | EP1612267A1 Cellulases from rumen |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611249A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 01/04/2006 | EP1611247A2 Cyp2s1 as target for diagnosis and therapy of skin diseases |
| 01/04/2006 | EP1611236A1 Method for the production of gla-residue containing serine proteases |
| 01/04/2006 | EP1611235A1 Novel alkaline protease |
| 01/04/2006 | EP1611234A2 Crystal structure of streptococcus undecaprenyl pyrophosphate synthase and uses thereof |
| 01/04/2006 | EP1611232A1 tdcBC/pckA GENE-INACTIVATED MICROORGANISM AND METHOD OF PRODUCING L-THREONINE USING THE SAME |
| 01/04/2006 | EP1610772A2 Retinoid replacements and opsin agonists and methods for the use thereof |
| 01/04/2006 | EP1610755A2 Phosphodiesterase 2a and methods of use |
| 01/04/2006 | EP1610752A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 01/04/2006 | EP1556482A4 Novel polypeptide having function of 7-keto-8-aminopelargonic acid synthase of plant and method for inducing growth inhibition and lethality by suppressing expression of the polypeptide |
| 01/04/2006 | EP1446494B1 Enzymatic process for the manufacture of l-ascorbic acid and d-erythorbic acid |
| 01/04/2006 | EP1407037B1 Process for manufacturing of tagatose |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1313851B1 Methods and reagents for molecular cloning |
| 01/04/2006 | EP1278867B1 Hcv ns2/3 fragments and uses thereof |
| 01/04/2006 | EP1250422B1 Myeloid colony stimulating factor and uses thereof |
| 01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
| 01/04/2006 | EP1218426B1 Dynamic coating |
| 01/04/2006 | EP1202744B1 PRODUCTION OF rhPBGD |
| 01/04/2006 | EP0992189B1 Animals carrying 25-hydroxylated vitamin d3-24-hydroxylase gene transferred thereinto |
| 01/04/2006 | EP0939130B1 Rna polymerase |
| 01/04/2006 | EP0923606B1 Antigenic fusionprotein carrying galalpha1,3gal epitopes |
| 01/04/2006 | EP0815209B1 Novel endoglucanases |
| 01/04/2006 | EP0673422B1 Cells with altered betaine catabolism, their preparation and their use, in particular for producing metabolites or enzymes |
| 01/04/2006 | CN1717496A Protein labelling with o6-alkylguanine-DNA alkyltransferase |
| 01/04/2006 | CN1717492A Process for preparing enantiomerically enriched (1s,4r) 1-acetoxy-4-hydroxycyclopent-2-ene |
| 01/04/2006 | CN1717487A Neomycin-phosphotransferase-genes and methods for the selection for recombinant cells producing high levels of a desired gene product |
| 01/04/2006 | CN1717481A Metabolically engineered micro-organisms having reduced production of undesired metabolic products |
| 01/04/2006 | CN1715462A Controllable biological degumming method for flax |
| 01/04/2006 | CN1715414A Genes for the biosynthesis of epothilones |
| 01/04/2006 | CN1715413A Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2006 | CN1715405A Method for one-step dry powdering molecular biological reagent |
| 01/04/2006 | CN1715404A Cyclic imide hydrolase gene and the use of its expression protein |
| 01/04/2006 | CN1715403A Process for preparing glutathion-5-transferase protein affinity chromatography medium and its use |
| 01/04/2006 | CN1715402A Biological enzyme activator |
| 01/04/2006 | CN1234868C Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof |
| 01/04/2006 | CN1234854C Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/04/2006 | CN1234853C Production method of corn super oxide dismutase multi-enzyme |
| 01/03/2006 | US6982363 UDP-glucose modifiers |
| 01/03/2006 | US6982325 Gene encoding protein having aurone synthesizing activity |
| 01/03/2006 | US6982314 Lawsonia intracellularis proteins, and related methods and materials |
| 01/03/2006 | US6982313 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982164 preferred derivatives comprise a mixture of amino acids, peptides and/or protein fractions derived from the extraction and optional hydrolysis of naturally occurring jojoba protein; use in cosmetics and as extenders |
| 01/03/2006 | US6982163 Process for preparing beta-fructofuranosidase enzyme and a process for producing fructooligosaccharides |
| 01/03/2006 | US6982162 Genetically engineered microorgaism for use as diagnostic tool |
| 01/03/2006 | US6982159 Trichoderma β-glucosidase |
| 01/03/2006 | US6982158 heating barley cell extracts in solution comprising magnesium and/or calcium to increase activity; phosphodiesterases; chromatography |
| 01/03/2006 | US6982157 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4 |
| 01/03/2006 | US6982144 Thermostable polymerases having altered fidelity and methods of identifying and using same |
| 01/03/2006 | US6982087 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 01/03/2006 | US6982083 Starch granules containing a recombinant polypeptide of interest, method for obtaining them, and their uses |
| 01/03/2006 | CA2329510C Promoter sequence which is expressed in anthers and in pollen |
| 01/03/2006 | CA2164849C Enzymatic compositions and methods for producing stonewashed look on indigo-dyed denim fabric |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 12/29/2005 | WO2005124012A1 New enzymatic bleaching system |
| 12/29/2005 | WO2005123929A2 Plastid transit peptides |
| 12/29/2005 | WO2005123926A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of cytokinin oxydase in the seeds |
| 12/29/2005 | WO2005123922A1 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same |
| 12/29/2005 | WO2005123921A1 Novel glycerol dehydrogenase, gene therefor, and method of utilizing the same |
| 12/29/2005 | WO2005123916A2 Glycosylation-disrupted factor vii variants |
| 12/29/2005 | WO2005123915A1 Stably maintained multiple copies of at least two orf in the same orientation |
| 12/29/2005 | WO2005123914A1 Improved methods of producing heterologous proteases |
| 12/29/2005 | WO2005123913A2 Reversibly modified thermostable enzyme compositions and methods of making and using the same |
| 12/29/2005 | WO2005123912A2 Thymidine kinase |
| 12/29/2005 | WO2005123911A2 Proteases |
| 12/29/2005 | WO2005123769A1 Hla-a2-binding protein originating in prostate-related antigen |
| 12/29/2005 | WO2005123760A2 Treating cancer |
| 12/29/2005 | WO2005123127A2 Methods for treating cancer using prss15 as a target |
| 12/29/2005 | WO2005123115A1 Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants |
| 12/29/2005 | WO2005122675A2 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proetins |
| 12/29/2005 | WO2005060384A3 Constructs for homogenously processed preparations of beta site app-cleaving enzyme |
| 12/29/2005 | WO2005028614A3 Construction of a gst-cbd fusion protein having several enzymatic activities |
| 12/29/2005 | WO2005002359A3 Modified starch, uses, methods for production thereof |